0000950170-24-073692.txt : 20240614 0000950170-24-073692.hdr.sgml : 20240614 20240614162003 ACCESSION NUMBER: 0000950170-24-073692 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240612 FILED AS OF DATE: 20240614 DATE AS OF CHANGE: 20240614 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nicholson Garry A CENTRAL INDEX KEY: 0001640861 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40603 FILM NUMBER: 241045100 MAIL ADDRESS: STREET 1: C/O TESARO, INC. STREET 2: 1000 WINTER STREET, SUITE 3300 CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TScan Therapeutics, Inc. CENTRAL INDEX KEY: 0001783328 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 825282075 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 880 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 857-399-9500 MAIL ADDRESS: STREET 1: 880 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 ownership.xml 4 X0508 4 2024-06-12 0001783328 TScan Therapeutics, Inc. TCRX 0001640861 Nicholson Garry A C/O TSCAN THERAPEUTICS, INC. 830 WINTER STREET WALTHAM MA 02451 true false false false false Stock Option (Right to Buy) 8.88 2024-06-12 4 A false 47500 0.00 A 2034-06-11 Voting Common Stock 47500 47500 D Stock Option (Right to Buy) 8.88 2024-06-12 4 A false 23750 0.00 A 2034-06-11 Voting Common Stock 23750 23750 D The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 12, 2025 and (ii) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service at such time. The shares subject to this option shall vest and become exercisable with respect to one-third of the shares on June 12, 2025, with the balance vesting thereafter in 24 equal monthly installments, subject to the Reporting Person's continued service at each such time. /s/ Zoran Zdraveski, Attorney-in-Fact 2024-06-14